scholarly journals Delayed hypersensitivity reaction to hyaluronic acid dermal filler post‐COVID‐19 viral infection

2021 ◽  
Vol 20 (5) ◽  
pp. 1549-1550 ◽  
Author(s):  
Debraj Shome ◽  
Komal Doshi ◽  
Sapna Vadera ◽  
Rinky Kapoor
Keyword(s):  
Hyaluronic Acid ◽  
Hypersensitivity Reaction ◽  
Viral Infection ◽  
Delayed Hypersensitivity ◽  
Dermal Filler ◽  
Delayed Hypersensitivity Reaction

scholarly journals Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Caroline Michèle Andrist ◽  
Lukas Jörg ◽  
Thomas Greuter ◽  
Anna Gschwend ◽  
Alex Straumann ◽  
...  
Keyword(s):  
Hypersensitivity Reaction ◽  
Eosinophilic Esophagitis ◽  
Systemic Reaction ◽  
Chronic Inflammatory Disease ◽  
Delayed Hypersensitivity ◽  
Caucasian Woman ◽  
Case Presentation ◽  
Commercial Test ◽  
Delayed Hypersensitivity Reaction ◽  
Subsequent Intake

Abstract Background Eosinophilic esophagitis (EoE) is a chronic inflammatory disease that has been known since the early 1990s. Swallowed topical corticosteroids (STC) belong to the therapeutic cornerstones. We describe a delayed hypersensitivity reaction to Jorveza®, a newly developed orodispersible budesonide tablet licensed for the treatment of eosinophilic esophagitis. Case presentation A 32-year-old Caucasian woman with EoE was newly treated with Jorveza®. Hours after the first intake, she felt a “strange pruritus” in the throat. This sensation worsened with each subsequent intake. On day 4 she developed oral mucosal symptoms (paresthesia of the tongue, sore and an itchy throat). Intraoral, throat and facial swellings, but no systemic reaction were observed. Patch testing using two commercial test series as well as the orodispersible budesonide tablet revealed a strong sensitization, proving a T cell mediated allergy to budesonide. Conclusions Orodispersible budesonide is increasingly prescribed for the treatment of eosinophilic esophagitis. The development of oropharyngeal symptoms after initiating should alert the treating physician to the possibility of a hypersensitivity reaction.

Delayed hypersensitivity reaction related to the use of pegfilgrastim

2014 ◽  
Vol 21 (6) ◽  
pp. 474-477 ◽  
Author(s):  
Aliakbar Dadla ◽  
Susan Tannenbaum ◽  
Breton Yates ◽  
Lisa Holle
Keyword(s):  
Hypersensitivity Reaction ◽  
Delayed Hypersensitivity ◽  
Delayed Hypersensitivity Reaction

A delayed hypersensitivity reaction to dentine primer in the guinea-pig

1995 ◽  
Vol 23 (5) ◽  
pp. 295-299 ◽  
Author(s):  
K. Katsuno ◽  
A. Manabe ◽  
K. Itoh ◽  
H. Hisamitsu ◽  
S. Wakumoto ◽  
...  
Keyword(s):  
Guinea Pig ◽  
Hypersensitivity Reaction ◽  
Delayed Hypersensitivity ◽  
Delayed Hypersensitivity Reaction

Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction

2009 ◽  
Vol 28 (2) ◽  
pp. 185-186 ◽  
Author(s):  
Simona Potenza ◽  
Guglielmo Nasti ◽  
Ottaiano Alessandro ◽  
Amelia Filippelli ◽  
Francesco Rossi ◽  
...  
Keyword(s):  
Case Report ◽  
Hypersensitivity Reaction ◽  
Respiratory Symptoms ◽  
Delayed Hypersensitivity ◽  
Delayed Hypersensitivity Reaction
Sign in / Sign up

Export Citation Format

Share Document